FIG 1.
(A) Ceftazidime (CAZ) and ceftazidime-avibactam (CAZ-AVI) MIC distributions for a collection of 190 P. aeruginosa bloodstream isolates recovered from a 10-hospital multicenter study performed in Spain. (B) CAZ and CAZ-AVI MIC distribution for the 46 isolates from the collection showing AmpC hyperproduction. (C) CAZ and CAZ-AVI MIC distribution for the 63 isolates from the collection showing an MDR profile.
